- Home
- ATNF vs QNRX Comparison
ATNF vs QNRX Comparison
Compare ATNF & QNRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATNF
- QNRX
- Stock Information
- Founded
- ATNF 2016
- QNRX 2018
- Country
- ATNF United States
- QNRX United States
- Employees
- ATNF N/A
- QNRX N/A
- Industry
- ATNF Biotechnology: Pharmaceutical Preparations
- QNRX Medical/Dental Instruments
- Sector
- ATNF Health Care
- QNRX Health Care
- Exchange
- ATNF Nasdaq
- QNRX Nasdaq
- Market Cap
- ATNF 3.8M
- QNRX 3.3M
- IPO Year
- ATNF N/A
- QNRX N/A
- Fundamental
- Price
- ATNF $0.83
- QNRX $9.60
- Analyst Decision
- ATNF
- QNRX
- Analyst Count
- ATNF 0
- QNRX 0
- Target Price
- ATNF N/A
- QNRX N/A
- AVG Volume (30 Days)
- ATNF 35.4K
- QNRX 12.9K
- Earning Date
- ATNF 08-11-2025
- QNRX 08-07-2025
- Dividend Yield
- ATNF N/A
- QNRX N/A
- EPS Growth
- ATNF N/A
- QNRX N/A
- EPS
- ATNF N/A
- QNRX N/A
- Revenue
- ATNF N/A
- QNRX N/A
- Revenue This Year
- ATNF N/A
- QNRX N/A
- Revenue Next Year
- ATNF N/A
- QNRX N/A
- P/E Ratio
- ATNF N/A
- QNRX N/A
- Revenue Growth
- ATNF N/A
- QNRX N/A
- 52 Week Low
- ATNF $0.66
- QNRX $5.01
- 52 Week High
- ATNF $17.75
- QNRX $54.95
- Technical
- Relative Strength Index (RSI)
- ATNF 35.60
- QNRX 64.78
- Support Level
- ATNF $0.95
- QNRX $8.04
- Resistance Level
- ATNF $1.04
- QNRX $8.58
- Average True Range (ATR)
- ATNF 0.08
- QNRX 0.46
- MACD
- ATNF -0.01
- QNRX 0.04
- Stochastic Oscillator
- ATNF 17.41
- QNRX 98.57
About ATNF 180 Life Sciences Corp.
180 Life Sciences Corp was formed as a clinical-stage biotechnology company, focused on the development of therapeutics for unmet medical needs in chronic pain, inflammation, and fibrosis by employing research, and, where appropriate, combination therapy. In addition, it has acquired certain source code and intellectual property relating to the back-end technology platform to operate an online blockchain casino, and moving forward, it plans to focus the majority of its operations on the creation of the online blockchain casino, while looking to monetize certain prior development-stage therapeutic product candidates for unmet medical needs. It has one reportable operating segment, iGaming.
About QNRX Quoin Pharmaceuticals Ltd.
Quoin Pharmaceuticals Ltd is a clinical stage specialty pharmaceutical company focused on developing and commercializing therapeutic products that treat rare and orphan diseases. Its pipeline comprises three products that collectively have the potential to target a broad number of rare and orphan indications, including Netherton Syndrome, Peeling Skin Syndrome, Palmoplantar Keratoderma, Epidermolysis Bullosa, and others.